switching from tirzepatide to semaglutide for weight loss between weight-loss medications Guide to Switching from Mounjaro

The end result is usually a foggy brain

Before billing modifier 51, clinicians should confirm whether NCCI bundling edits allow separate reimbursement

AOD-9604 Originally used as an anti-obesity drug, AOD 9604 is a modified form of amino acids 176-191

The effect appears to be stronger with a high BMI than with a low BMI

Glucagon-like peptide-1 (GLP-1)-based agents (including GLP-1 analogues and dipeptidyl peptidase 4 inhibitors) have been recently approved as new therapeutic options for patients with type 2 diabetes, based upon the evidence that GLP-1 can stimulate glucose-dependent insulin secretion from pancreatic cells